Ataxin-3 (ATXN3), the disease protein in spinocerebellar ataxia type 3 (SCA3), binds to target gene promoters and modulates transcription by interaction with transcriptional regulators. Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene. Upon oxidative stress, ATXN3 and FOXO4 translocate to the nucleus, concomitantly bind to the SOD2 gene promoter and increase the expression of the antioxidant enzyme SOD2. Compared with normal ATXN3, mutant ATXN3 has a reduced capability to activate the FOXO4-mediated SOD2 expression and interferes with binding of FOXO4 to the SOD2 gene promoter. These findings are consistent with a downregulation of SOD2 in pontine brain tissue and lymphoblastoid cell (LC) lines of SCA3 patients. In response to oxidative stress, LCs from SCA3 patients show a specific impairment to upregulate SOD2 expression in correlation with a significantly increased formation of reactive oxygen species and cytotoxicity. The impairment to increase the expression of SOD2 under oxidative stress conditions is associated with a significantly reduced binding of FOXO4 to the SOD2 gene promoter in SCA3-LCs. Finally and consistent with a regulatory role of ATXN3 in SOD2 expression, knockdown of endogenous ATXN3 by RNA interference represses the expression of SOD2. These findings support that ATXN3 plays an important role in regulating the FOXO4-dependent antioxidant stress response via SOD2 and suggest that a decreased antioxidative capacity and increased susceptibility towards oxidative stress contributes to neuronal cell death in SCA3.
INTRODUCTION
Polyglutamine (polyQ) diseases are dominantly inherited, neurodegenerative disorders caused by expansion of CAG repeats and expression of polyQ-expanded proteins. Nine polyQ diseases including Huntington's disease (HD), spinal bulbar muscular atrophy, dentatorubropallidoluysian atrophy and six dominantly inherited spinocerebellar ataxias (SCA1, 2, 3, 6, 7 and 17) are caused by polyQ-expanded proteins. Diverse cellular processes have been implicated in the pathogenesis, including the formation of protein aggregates, impaired protein quality control, mitochondrial function and transcriptional regulation (1) .
ATXN3, the disease protein in SCA3, interacts with several transcriptional components such as the TATA-binding protein-associated factor TAFII130 (2,3), the cAMP response element binding protein CBP (4, 5) , the DNA repair protein RAD23 (6), the nuclear corepressor receptor NCoR and the histone deacetylases HDAC3 and HDAC6 (7, 8) . Normal ATXN3 is involved in the expression of genes implicated in stress response and extracellular matrix modelling, whereas * To whom correspondence should be addressed at: Department of Neurology, University of Bonn, Sigmund-Freud-Str. 25 , 53105 Bonn, Germany. Tel: +0049 228 287 19882; Fax: +0049 228 287 11567; Email: b.evert@uni-bonn.de mutant ATXN3 is associated with upregulation of genes mainly involved in inflammatory reactions (9 -11) . Previous studies have shown that ATXN3 modulates gene transcription through chromatin binding and recruitment of histone deacetylating complexes to target gene promoters (8, 12) . Although these findings clearly indicate a role for ATXN3 in transcriptional regulation, it is unclear which molecular pathways are influenced by ATXN3. Heat stress results in nuclear translocation and increased transcriptional activity of ATXN3 (13, 14) , suggesting that the transcriptional role of ATXN3 is linked to cellular stress response pathways.
To identify ATXN3-regulated pathways, we screened for transcription factors specifically interacting with ATXN3 and identified the forkhead box class O (FOXO) transcription factor 4 (FOXO4). FOXO family transcription factors are involved in various cellular processes, including regulation of cell cycle arrest, differentiation, cell death and resistance to cellular oxidative stress (15, 16) . We here provide evidence that normal ATXN3 functions as a redox-sensitive, transcriptional coactivator of the superoxide dismutase 2 (SOD2) gene within the FOXO-mediated oxidative stress response. Our data show that a concomitantly increased binding of ATXN3 and FOXO4 to the SOD2 promoter is associated with upregulation of the antioxidant enzyme SOD2 in response to oxidative stress. This important cytoprotective function of ATXN3 is impaired in SCA3 lymphoblastoid cell (LC) lines which showed reduced expression levels of SOD2 resulting in increased formation of reactive oxygen species (ROS) and cytotoxicity under oxidative stress conditions. These findings suggest that mutant ATXN3 is associated with a significantly reduced capability to counteract oxidative stress that contributes to neuronal cell death in SCA3.
RESULTS

ATXN3-interacting transcription factors
To identify ATXN3-interacting transcription factors, a transcription factor profiling was conducted in HeLa cells and transgenic CSM14.1 cell lines stably expressing non-expanded (Q23) and expanded (Q70) human full-length ATXN3 (17) . Nuclear extracts of the different cell lines were pre-incubated each with biotin-labelled DNA-binding probes, immunoprecipitated with an anti-ATXN3 antibody and hybridized to a DNA array containing 345 different transcription factor consensus binding sequences. In total, 43 potential ATXN3-interacting transcription factors showing enhanced binding to their respective consensus motifs were identified. Most of the identified transcription factors were cell-type specific or overlapped in two of three cell lines (for a complete list see Supplementary Material, Fig. S1 ). Among the ATXN3-interacting transcription factors common to all cell lines, one showed a significantly enriched binding to the consensus motif of the forkhead box class O (FOXO) transcription factor 4 (FOXO4) indicating that FOXO4 interacts with ATXN3 independently of the cell type and polyglutamine length.
FOXO4 interacts with the N-terminal Josephin domain of ATXN3
Coimmunoprecipitations and glutathione S-transferase (GST) fusion protein pulldown experiments were performed to confirm the interaction of ATXN3 with FOXO4. Coimmunoprecipitations using a nuclear extract from human pons tissue showed that endogenous ATXN3 interacts with endogenous FOXO4 (Fig. 1A) . Coimmunoprecipitations of HeLa cells transiently transfected with HA-tagged FOXO4 and ATXN3 variants of different polyQ size (Q2, Q22, Q71 and Q123) showed that ATXN3 coprecipitates with FOXO4 independently of the polyQ length (Fig. 1B) . For pulldown studies, GST fusion proteins of ATXN3 with Q23 or Q70 repeats as well as truncated ATXN3 containing the Josephin domain only or the Josephin domain in conjunction with two ubiquitin-interacting motifs (UIM) were incubated with nuclear extracts of mouse brain tissue, CSM14.1 and HeLa cells (Fig. 1C) . Endogenous FOXO4 was enriched selectively from all nuclear extracts with all variants of GST -ATXN3 fusion proteins, but not with GST alone (Fig. 1C) , indicating that ATXN3 interacts via its N-terminal Josephin domain containing region with FOXO4. This was also confirmed using a peptide array covering the complete amino acid sequence of ATXN3. Fig. S2) . Notably, the proteinprotein interaction between ATXN3 and FOXO4 is not associated with recruitment of FOXO4 into ATXN3-containing nuclear inclusions (NIs) since coimmunofluorescence staining of human pons sections of SCA3 patients showed no colocalization of FOXO4 to ATXN3-positive NIs (Supplementary Material, Fig. S3 ). Together, these findings demonstrate that ATXN3 associates independently of the polyQ repeat via its Josephin domain with FOXO4.
ATXN3 coactivates the FOXO4-dependent gene transcription
To study the functional effects of ATXN3 on FOXO4-mediated gene transcription, HeLa cells were transfected with a luciferase reporter containing two tandem consensus DNA-binding sites (4xDBE) of FOXO and expression plasmids for FOXO4, ATXN3Q23 or ATXN3Q70. Transfection of FOXO4 induced an 18-fold increase in the FOXO-responsive reporter activity compared with controls transfected with a beta-galactosidase (b-Gal) expression plasmid only (Fig. 2A) . The coexpression of ATXN3Q23 and FOXO4 resulted in a 70-fold synergistic transcriptional activation of the FOXO-dependent reporter, whereas coexpressed mutant ATXN3Q70 led only to a 40-fold increase in the reporter activity ( Fig. 2A) .
Similarly, HeLa cells transfected with a luciferase reporter containing 1.4 kb of the proximal FOXO-responsive human SOD2 gene promoter (21412 to +1) and the FOXO4 expression plasmid showed a 2.5-fold induction of reporter activity compared with basal levels of b-Gal-transfected controls (Fig. 2B) . Coexpression of FOXO4 and ATXN3Q23 resulted in a 4-fold activation of the reporter, whereas Human Molecular Genetics, 2011, Vol. 20, No. 15 2929 coexpressed mutant ATXN3Q70 displayed luciferase activities not different from cells transfected with FOXO4 and b-Gal (Fig. 2B) . Thus, normal ATXN3 enhanced FOXO4 transcriptional activity and activated SOD2 transcription, whereas mutant ATXN3 showed an impaired capability to activate FOXO4-dependent transcription.
Ubiquitination of FOXO4 is not modified by ATXN3 deubiquitinating function
The finding that FOXO4 interacted similarly with both normal and mutant ATXN3 without being recruited into NIs suggested that ATXN3 modifies the transcriptional activity of FOXO4. Recently, it has been shown that FOXO4 is monoubiquitinated in response to oxidative stress leading to increased transcriptional activity of FOXO4 (18, 19) . In contrast, polyubiquitination of FOXOs inhibits transcriptional activity and promotes proteasomal degradation of FOXO factors (20, 21) . ATXN3 binds and hydrolyses polyubiquitinated proteins (22) (23) (24) and, hence, may antagonize polyubiquitination and degradation of FOXO4. To study ubiquitin-specific modifications of FOXO4, Flag-tagged ubiquitin (Flag-Ub), HA-FOXO4 and different ATXN3 variants were coexpressed in HEK293 cells and, subsequently treated with hydrogen peroxide (H 2 O 2 ) or left untreated. Immunoprecipitation of ubiquitinated proteins from untreated cells with anti-Flag beads and immunodetection of HA-FOXO4 revealed two discrete ubiquitinated FOXO4 bands (Fig. 3A) . Treatment with H 2 O 2 led to a marked increase in these ubiquitinated FOXO4 conjugates, although no changes in the ubiquitination status of FOXO4 were found when normal ATXN3Q23, a catalytically inactive form of normal ATXN3 (AT3Q23C14A), or mutant ATXN3Q70 were coexpressed with FOXO4 ( Fig. 3A and B). However, an enrichment of ubiquitinated FOXO4 was always observed when ATXN3 variants were coexpressed with FOXO4 and did not occur in control transfections without ATXN3 ( Fig. 3A and B) . Similar results were obtained when HeLa cells were transfected and exposed to H 2 O 2 under the same conditions (data not shown), indicating that ATXN3 supports protein stability of FOXO4 independently of its catalytic activity or polyQ repeat length.
Nuclear translocation of ATXN3 and FOXO4 correlates with increased SOD2 expression
The subcellular localization and transcriptional activity of FOXO4 are regulated by stress stimuli. The inactive form of FOXO4 resides in the cytoplasm, whereas the activated transcription factor translocates to the nucleus upon oxidative stress (19, 25) . Similarly, oxidative stress has been shown to CSM14.1 and wild-type mouse brain incubated with recombinant GST, GST-Jos, GST-Jos/UIM, GST-AT3Q23 and GST-AT3Q70 ( * ). GST fusion proteins were precipitated using glutathione-sepharose beads and analysed by WB with antibodies against FOXO4 (a-Afx1) and GST (a-GST). Endogenous FOXO4 was selectively enriched from all nuclear extracts with all variants of GST fusion proteins but not with GST alone. The structure and containing regions of the GST-ATXN3 fusion constructs are shown schematically, together with their respective truncation sites and locations of the polyQ repeat. The location of the conserved Josephin domain and the UIM in ATXN3 are shown in grey boxes. Input represents 10% of the nuclear protein amount used for each pulldown.
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Human Molecular Genetics, 2011, Vol. 20, No. 15 result in nuclear translocation of ATXN3 (14) . Treatment of HeLa cells with H 2 O 2 induced a rapid and time-dependent nuclear translocation of both endogenous FOXO4 and ATXN3 (Fig. 4A) . Concurrently, the endogenous expression of FOXO-responsive SOD2, which scavenges ROS, increased in the cytoplasmic fraction after 15-30 min treatment with Thus, nuclear translocation of both endogenous ATXN3 and FOXO4 proceeded through increased production of ROS and correlated with an increased expression of the antioxidant enzyme SOD2.
Impaired SOD2 expression in LCs and pons tissue from SCA3 patients
To study the biological correlations between oxidative stress and SCA3 disease pathogenesis, we established LC lines from SCA3 patients and unaffected control subjects. LCs from SCA3 patients (SCA3-LCs) showed significantly decreased mRNA ( In response to oxidative stress, SCA3-LCs failed to increase mRNA levels of SOD2, whereas SOD2 transcripts in Ctrl-LCs significantly increased after 5 min treatment with H 2 O 2 ( Fig. 5E ). These transcriptional changes in response to H 2 O 2 treatment were also reflected at the SOD2 protein level. Ctrl-LCs showed increased SOD2 protein levels after treatment with H 2 O 2 , while the SOD2 protein expression remained unchanged in SCA3-LCs exposed to H 2 O 2 ( Fig. 5F ). H 2 O 2 treatment did not affect the overall levels of ATXN3, FOXO4 or actin in whole cell lysates of LCs.
Increased ROS formation and cytotoxicity in SCA3-LCs upon oxidative stress
Since SOD2 is required for detoxification of ROS, we analysed if the impaired SOD2 expression in SCA3-LCs is associated with an increased ROS formation. Measurement of ROS using the fluorescent dye dihydrodichlorofluorescein showed enhanced basal levels of ROS already in untreated To test whether SCA3-LCs were also more susceptible to oxidative stress, we determined cell viability of the LC lines exposed to H 2 O 2 in a 72 h time course. While untreated LCs from controls and SCA3 patients showed a normal growth rate and cell viability, treatment with H 2 O 2 strongly decreased survival of all LC lines (Fig. 6B) . However, SCA3-LCs were more sensitive than Ctrl-LCs with 61 versus 86% viable cells for SCA3-and Ctrl-LCs, respectively, after 24 h treatment with H 2 O 2 (Fig. 6B) . Prolonged exposure to H 2 O 2 for 48 and 72 h further significantly decreased cell viability of SCA3-LCs (48 h: 35 versus 66% and 72 h: 5 versus 38% for SCA3-and Ctrl-LCs, respectively). These findings strongly suggest that the impaired upregulation of the SOD2 expression in response to oxidative stress is associated with a significant formation of ROS and increased cytotoxicity in SCA3-LCs.
ATXN3 has a regulatory role in SOD2 expression
To determine whether ATXN3 is required for SOD2 expression, we generated a lentiviral vector expressing an ATXN3-specific short hairpin RNA (shRNA) that silenced the expression of the ATXN3 gene (LVshATXN3) in LCs. Increasing amounts of LVshATXN3 resulted in a concurrent decrease in endogenous ATXN3 in Ctrl-and SCA3-LCs ( Fig. 7A and B) . Importantly, knockdown of the endogenous ATXN3 expression led to a simultaneous decrease in SOD2 expression in Ctrl-and SCA3-LCs, while the protein levels of actin remained constant. In contrast, infection with a control lentiviral vector carrying scrambled shRNA (LVshscr) had no significant effect on the expression of ATXN3 or SOD2 in Ctrl-or SCA3-LCs ( Fig. 7A and B) . showed that SOD2 expression is reduced in SCA3 both at the mRNA and protein level. (E) RT-qPCR analysis of SOD2 mRNAs in LC lines from each four controls and SCA3 patients after treatment with 200 mM H 2 O 2 . LCs from SCA3 patients failed to increase SOD2 mRNA levels, whereas controls showed a significant increase in SOD2 transcription already after 5 min. The results were averaged from triplicates of each LC line and are presented as the mean + SEM ( * P , 0.05). (F) Representative western blot analysis of ATXN3, FOXO4, SOD2 and actin. Whole cell lysates of LCs from controls showed increased expression of SOD2 protein after 5 min exposure to 200 mM H 2 O 2 , whereas SOD2 protein levels remained unchanged in LCs from SCA3 patients.
These findings are consistent with a regulatory role of ATXN3 in SOD2 expression.
Altered binding of ATXN3 and FOXO4 to the SOD2 promoter in SCA3-LCs FOXO transcription factors bind to one FOXO DNA-binding element in the human SOD2 gene promoter and activate the expression of SOD2 in response to oxidative stress (26) . This promoter region also contains putative ATXN3-binding sites according to our previously identified DNA-binding motifs for ATXN3 (8) . Chromatin immunoprecipitation (ChIP) analyses of LCs from controls and SCA3 patients revealed that both endogenous ATXN3 and FOXO4 bind in vivo to the human SOD2 gene promoter region containing the FOXO-binding element (21398 to 21243) (Fig. 8) . In unstressed Ctrl-LCs, the basal levels of ATXN3 bound to the SOD2 promoter were 2-fold lower than in SCA3-LCs. Treatment with H 2 O 2 led to a significantly enriched binding of ATXN3 to the SOD2 promoter in Ctrl-LCs, but did not further increase the levels of promoter-bound ATXN3 in SCA3-LCs. Similarly, oxidative stress induced a significantly increased binding of FOXO4 only in Ctrl-LCs (Fig. 8) . The levels of promoter-bound FOXO4 in SCA3-LCs did not change in response to oxidative stress and were significantly lower than in Ctrl-LCs exposed to H 2 O 2 . The stress-induced changes in SOD2 promoter binding of ATXN3 and FOXO4 were specific since treatment with H 2 O 2 did not induce significant changes in the amount of chromatin-associated histone H3 in any of the LC lines (Fig. 8) . These results show that a concomitant and increased binding of both ATXN3 and FOXO4 to the SOD2 promoter is involved in the upregulation of SOD2 in response to H 2 O 2 . Moreover, these findings suggest that an increased association of mutant ATXN3 to the SOD2 promoter region containing the FOXO DNAbinding element prevents stress-induced FOXO4 binding and upregulation of SOD2 in SCA3-LCs.
DISCUSSION
We here provide evidence that ATXN3 acts as transcriptional coactivator of the SOD2 gene within the FOXO-regulated oxidative stress response. FOXO transcription factors are known to protect against cell death evoked by oxidative stress or glucose deprivation (26, 27) . SOD2 is a well known target gene of the FOXO transcription factor subfamily and is essential for the removal of ROS (16) . The findings of the present study demonstrate that ATXN3 interacts with FOXO4 and enhances the FOXO4-dependent transcription of SOD2. In response to oxidative stress, ATXN3 and FOXO4 translocate to the nucleus, bind to the very same region of the SOD2 gene promoter and increase the expression of SOD2 in Ctrl-LCs. In contrast, LCs from SCA3 patients exposed to oxidative stress showed reduced binding of FOXO4 to the SOD2 promoter in correlation with an impaired upregulation of SOD2. The decreased SOD2 expression in SCA3-LCs was further associated with an increased formation of ROS and significant cytotoxicity in the presence of oxidative stress, suggesting that the ATXN3-FOXO4-modulated upregulation of SOD2 gene expression is impaired in SCA3.
Previously, it has been shown that beta-catenin is required for FOXO4-mediated expression of SOD2 (28) . Beta-catenin translocates to the nucleus, interacts directly with FOXO4 and enhances FOXO4 transcriptional activity. Similarly, we found that FOXO4 induced transcription of different FOXO reporters and coexpressed ATXN3 enhanced transcriptional activity of FOXO4. Both normal and mutant ATXN3 were capable to interact with FOXO4 independently of the polyQ length but only normal ATXN3 activated the FOXO4-dependent expression of the SOD2 gene promoter and (29). FOXO transcription factors bind to an inverse FOXObinding element in the proximal region of the human SOD2 gene promoter (30) and increase the expression of SOD2 (26) . Similarly, and consistent with a regulatory role of ATXN3 in SOD2 transcription, we found that ATXN3 binds to the very same region of the human SOD2 gene promoter encompassing the FOXO-binding site and knockdown of endogenous ATXN3 by RNA interference resulted in decreased expression of SOD2. In response to oxidative stress, the SOD2 promoter region was increasingly bound by ATXN3 and FOXO4 in correlation with the nuclear translocation of both proteins and increased expression of SOD2. These simultaneous, stress-induced processes support that normal ATXN3 acts as a redox-sensitive, coactivator of the FOXO4-dependent stress response. The coactivator function of ATXN3 in oxidative stress signalling, however, appears to be affected in SCA3. In SCA3-LCs, expression of SOD2 and the levels of promoter-bound ATXN3 and FOXO4 did not increase upon oxidative stress, instead SOD2 expression and binding of FOXO4 to the SOD2 promoter were significantly lower than in Ctrl-LCs. These findings suggest that an impaired binding of transcriptionally active FOXO4 to the SOD2 promoter prevents upregulation of SOD2 in SCA3-LCs in response to oxidative stress. One possible explanation for the loss of FOXO4-mediated upregulation of SOD2 may be related to the increased promoter occupancy of ATXN3 present already in unstressed SCA3-LCs. An aberrantly increased association of mutant ATXN3 in the promoter region of the SOD2 gene could interfere with binding of FOXO4 to the SOD2 promoter and transcriptional activation of the SOD2 gene expression.
The cellular localization and transcriptional activity of FOXO factors are regulated by posttranslational modifications (31) . In response to increased cellular oxidative stress, FOXO4 is monoubiquitinated by the E3 ligase Mdm2 leading to nuclear translocation and increased transcriptional activity of FOXO4 (18, 19) . In contrast, polyubiquitination of FOXOs by the E3 ligase Skp2 inhibits transcriptional activity and promotes proteasomal degradation of FOXOs (20, 21) . The activity of FOXO4 is further inhibited by the deubiquitinating (DUB) enzyme USP7 which removes monoubiquitins and changes FOXO4 localization from the nucleus to the cytosol (18) . ATXN3 is a DUB that preferentially binds polyubiquitin chains and produces reaction products with four or less ubiquitins (7, (22) (23) (24) and, thus, may modify the ubiquitination and activity of FOXO4 by interacting with FOXO4. We found that oxidative stress induced a marked increase in ubiquitination of FOXO4, although the overall ubiquitination status of FOXO4 was unchanged when normal, catalytically inactive or mutant ATXN3 were coexpressed with FOXO4. However, coexpression of ATXN3 led to enriched cellular FOXO4 protein levels, suggesting that ATXN3 stabilizes the fraction of transcriptionally active FOXO4 and thereby prolongs expression of the SOD2 gene. Accumulation and activation of FOXO4 in the nucleus in response to stress signals is thought to be a result of its stabilization, mediated by mechanisms that decrease the rate of its degradation (16) .
Recently, we and others showed that ATXN3 is phosphorylated and translocated to the nucleus in response to heat or oxidative stress stimuli (13, 14) . ATXN3 thus may function as a cytoplasmic signal transducer to induce an adequate stress response and to protect cells against stress stimuli. This protective function of ATXN3 appears to be impaired, at least, in LCs from SCA3 patients. Under normal or unstressed conditions, SCA3-LCs not only showed reduced expression levels of SOD2 but also increased basal ROS levels. When exposed to oxidative stress, SCA3-LCs did not increase SOD2 expression and revealed a significantly increased formation of ROS that correlated with an increased cytotoxicity. These findings suggest that the reduced expression of SOD2 found in LC lines and brain tissue from SCA3 patients most likely causes an impaired capability to remove ROS and increased sensitivity to oxidative stress stimuli in SCA3. Genetic manipulations of SOD2 have demonstrated that altering the level of SOD2 expression is critical for cellular function and life span. In mice, homozygous deletion of SOD2 results in a severe postnatal phenotype, including degeneration of neurons in the basal ganglia and brain stem, and progressive motor disturbances (32) . In contrast, heterozygous knockout mice of SOD2 with a lifelong reduced SOD2 content are viable but show increased oxidative damage, increased sensitivity to apoptosis and impaired mitochondrial respiration in various tissues (33) (34) (35) (36) . Oxidative stress has been defined as an imbalance between the elevated level of ROS and/or impaired function of the antioxidant defence system (37) . In a late onset disease such as SCA3, a permanently reduced expression of SOD2 may impair proper removal of superoxides and result in a constant accumulation of oxidative damage over decades contributing to neurodegeneration. In support of this, oxidative stress has been shown to play a key role also in other neurodegenerative diseases, such as HD (38) .
Model systems of amyotrophic lateral sclerosis have shown that proteotoxic stress induced by expression of mutant human proteins itself can be associated with a reduced expression of SOD2 (39) . However, although we cannot exclude that proteotoxic stress contributes to reduced SOD2 expression in SCA3, it seems more likely that mutant ATXN3 interferes with the recruitment of functional, FOXO4-containing transcriptional complexes to the SOD2 gene promoter and upregulation of the SOD2 gene expression. This is corroborated by the finding that SCA3-LCs showed aberrantly increased levels of promoterbound ATXN3 already under unstressed conditions. The downregulation of SOD2 in both LC lines and post-mortem brain tissue from SCA3 patients could then be the result of a dominant-negative effect of mutant ATXN3. A dominantnegative effect has also been proposed for the deregulated expression of the dopamine D2 receptor (DRD2) gene in the striatum of transgenic HD mice and human HD cases. Mutant huntingtin containing the expanded polyQ tract accumulates in the nucleus and interacts with the polyQ-rich domains of TAFII130 and Sp1 thereby preventing their DNA binding and transcriptional activation of the DRD2 gene (40 -42) . Although the exact mechanisms of the pathophysiological processes in SCA3 are yet unclear, the findings of the present study support the conclusion that normal ATXN3 has an important physiological function to protect cells from oxidative damage. This particular function of ATXN3 in the oxidative stress response probably explains the mild phenotype in knockout models of ATXN3 (43, 44) . Under normal conditions, the loss of wild-type ATXN3 may not affect the lifespan or result in a disease phenotype. However, since ATXN3 translocates to the nucleus specifically in response to stress stimuli, it will be necessary to reassess the existing knockout models of ATXN3 whether they develop a disease phenotype under stress conditions. In addition, it will also be important to study gene expression changes in these models since ATXN3 knockouts in C. elegans have shown dysregulation of several genes involved in the ubiquitin -proteasome system, transcriptional regulation, structure/motility and signal transduction (45) . Most recently, an important role of ATXN3 in lifespan regulation and stress resistance through the insulin -insulin-like growth factor 1 signalling pathway has been demonstrated in C. elegans (46) . A homologue of FOXO4 in C. elegans, DAF16, proceeds through the same pathway and promotes longevity and stress resistance (47) . Together with these data, our findings support the idea that ATXN3 acts in conjunction with FOXO4 in the conserved FOXO-dependent stress signalling pathway. Additional studies are needed to dissect the protective roles of ataxin-3 and its function in modulating the human disease course. The present study, so far, suggests that an impaired antioxidative capacity and increased susceptibility towards oxidative stress promotes neuronal cell death in SCA3. Since the brain is known to possess the highest oxygen metabolic rate of any organ in the body, deleterious effects of oxidative stress stimuli can be expected to be implicated in the neurodegenerative process in SCA3. Given the protective role of normal ATXN3 in the FOXO4-mediated antioxidant defence system, strategies increasing the cellular antioxidative capacity may be considered an effective therapeutic way to confer neuroprotection in SCA3.
MATERIALS AND METHODS
Cell lines and tissue samples
HeLa and HEK293 cells were cultured at 378C with 5% CO 2 in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal calf serum, 100 U/ml penicillin and 100 mg/ml streptomycin. Rat mesencephalic CSM14.1 clonal cell lines stably expressing normal (Q23) or expanded (Q70) human full-length AT3 were cultured as previously described (17) . LC lines were established from eight controls and 13 SCA3 patients as described by Neitzel (48) . Briefly, peripheral blood mononuclear cells were isolated from heparinized blood samples by ficoll density gradient centrifugation and infected with Epstein -Barr -Virus particles taken from the culture medium of B95-8 cells. After 6 weeks, LC lines were characterized by antibody staining and fluorescence-activated cell sorting analysis for cell population purity. LC lines containing at least 99% B lymphocytes were used for experiments. The SCA3 brain tissues were derived from two patients with genetically confirmed diagnosis of SCA3 (one female of 59 years and one male of 62 years) and two unaffected individuals (2 males of 51 and 64 years) without a history of neurological illness served as control.
Interaction array
For transcription factor profiling, 4 × 10 6 cells of each the Q23 and Q70 cell lines were seeded on 10 cm plates. After 4 days, cells were collected and nuclear protein complexes were prepared using the nuclear complex Co-IP kit (Active Motif, Rixensart, Belgium). The nuclear protein extracts (each 500 mg) of the CSM14.1 cell lines and of a control nuclear extract from HeLa cells were incubated each with biotin-labelled DNA-binding probes, immunoprecipitated with an anti-ATXN3 antibody (NT-MJD) and hybridized to the TranSignal TF-TF Interaction Arrays (Panomics, Fremont, CA, USA) according to the instructions of the manufacturer. The hybridization signals were quantified densitometrically using Quantity One (BioRad) and normalized to the corresponding signals obtained with an unspecific rabbit IgG control antibody. A minimal threshold of signal intensity was set at a value of .5 (relative signal intensity, on a scale ranging from 1 to 40).
Cell lysates and immunoprecipitations
Whole cell lysates of lymphoblastoid or transfected HeLa cells were prepared in radioimmunoprecipitation assay (RIPA) buffer as previously described (8) . Cells were disrupted by passage through a 21-gauge needle and clarified by centrifugation at 12 000g. Nuclear extracts of HeLa, Q23, Q70 cells, human pons and mouse brain tissue for immunoprecipitation and GST pulldown experiments were prepared as previously described (8) . For immunoprecipitation, 400 mg of protein of the HeLa cell lysates or nuclear human pons extract were incubated with the indicated antibody (1 -2 mg), followed by incubation with protein G-sepharose beads (Amersham Biosciences, Germany). Beads were washed twice with RIPA buffer, once with 50 mM Tris pH 8.0 and boiled in 2× Laemmli loading buffer. The antibodies used for immunoprecipitation were anti-AT3 (NT-MJD), rabbit polyclonal antiAfx1X (N-80, Santa Cruz Biotechnology), monoclonal mouse anti-HA.11 (clone 16B12, Covance) and rabbit control IgG (Santa Cruz).
Ubiquitination analysis
HEK293 cells were plated in 75 cm 2 flasks at a density of 8 × 10 5 one day prior transfection. Cells were transfected with the indicated plasmids using JetPEI transfection reagent (Polyplus Transfections) according to the manufacturer's instructions. Forty-eight hours after transfection, cells were left untreated or treated with 500 mM H 2 O 2 for 1 h and lysed by sonication in immunoprecipitation buffer [containing 50 mM Tris pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, Complete (Protease-Inhibitor-Mix, Roche), 20 mM N-ethylmaleimide, 0.5% NP40]. Immunoprecipitations were performed using 600 mg protein of the HEK293 cell lysates and anti-FLAG M2 agarose beads (Sigma) according to the instructions of the manufacturer. Immunoprecipitates were analysed by western blot.
Reporter and expression constructs
The luciferase reporter constructs containing two tandem consensus binding sites of FOXO (4xDBE) and the proximal region of the human SOD2 gene promoter were generated in the promoter-less luciferase reporter vector pGL4. 23 The eukaryotic expression vectors pcDNA-AT3Q23, -AT3Q23C14A and -AT3Q70 encoding full-length human normal or expanded ATXN3 were described previously (8) . The pcDNA3.1-AT3Q2, -AT3Q22, -AT3Q71 and -AT3Q123 expression vectors were described previously (49) . The HA (hemagglutinine)-tagged FOXO4 expression vector was generated by first amplifying the HA-tag from the pTL3 vector (HA-For: TATACGCGTACTC ACTATAGGGCAAATTGCCG; HA-Rev: TATACGCGTGG ATCCGGATCTCAAGCTAGCGTAGTC) and subcloning into pCR2.1-TOPO (Invitrogen). Then, the HA insert was released with BamHI and BstXI and subcloned into pcDNA 3.1 Hygromycin (-) vector (Invitrogen). In a second step, the FOXO4 cDNA was amplified by PCR from human cerebellar cDNA with KpnI-flanked forward and reverse primer (FOXO4-For: GGTACCGATCCGGGGAATGAGAAT; FOX O4-Rev: GGTACCCACCTGTGTGTGACCAGACC) and subcloning into the KpnI site of pcDNA 3.1 vector. The 3xFlag-ubiquitin construct was generated by cloning an ubiquitin cDNA fragment into the HindIII and BamHI sites of the p3xFlagCMV10 vector (Sigma). The expression plasmid pCMV-b-galactosidase (Clontech) was used as mock transfection control. The N-terminal GST-tagged ATXN3Q23 and ATXN3Q70 fusion constructs for bacterial expression were generated by subcloning the BamHI cDNA inserts from the above pcDNA3-AT3 expression vectors into the BamHI site of pGEX-6P-1 (Amersham Biosciences). The truncated ATXN3 constructs containing the Josephin domain only or the Josephin domain in conjunction with the two UIM were generated by PCR amplification of pcDNA-AT3Q23 using a forward BamHI-flanked primer (ATXN3-For: GGATCCGAGTCC ATCTTCCACGAGA AAC) together with a reverse BamHIflanked primer (Jos-Rev: GGATCCGTTGTGCT AATTCTTCTCCAATAAG) or a reverse BamHI-flanked primer (UIM-Rev: GGATCCGATTTGTACCTGATGTC TGTGTCATATC). The resulting PCR products were subcloned into the BamHI site of pGEX-6P-1. The N-terminally His-tagged FOXO4 fusion construct for bacterial expression was generated by subcloning the above FOXO4 cDNA KpnI insert into the pET32b+ vector (Novagen, Merck, Germany). All constructs were verified by sequencing.
Protein expression and GST pulldown
The truncated and full-length GST-ATXN3 fusion proteins were expressed in E. coli BL21 for 3 h at 378C upon induction with 0.1 mM isopropyl b-D-thiogalactoside (IPTG). Collected cells were disrupted by sonication in buffer A [50 mM sodiumphosphate pH 8, 100 mM NaCl, 10% (v/v) glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, protease-inhibitor mixture (Complete Mini; Roche Applied Science)] containing 1% (v/v) Triton X-100. After centrifugation at 30 000g, the supernatant was incubated with 2 ml of glutathione-sepharose beads (50% slurry, Sigma) for 30 min at 48C. Beads were washed with buffer A (1 M NaCl, 1% Triton X-100) and bound GST proteins were eluted with buffer A containing 20 mM reduced glutathione. All recombinant proteins were dialysed against buffer C [20 mM Tris pH 8, 150 mM KCl, 0.1 mM ethylenediaminetetraacetic acid, 10 % (v/v) glycerol, 0.1 mM dithiothreitol]. His-tagged FOXO4 was expressed in E. coli BL21 for 4 h at 378C upon induction with 0.1 mM IPTG and purified on Ni-NTA affinity columns according to the instructions of the manufacturer (Qiagen, Germany). For pulldown experiments, the purified GST -ATXN3 fusion proteins (0.05 mM) were pre-incubated for 1 h at 48C with glutathione beads, washed and incubated for 1 h at 48C with 400 mg of the indicated nuclear extracts. Then, beads were washed twice with RIPA buffer, once with 50 mM Tris pH 8.0 and boiled in 2× Laemmli loading buffer.
Western blot analysis
Western blot analysis was performed as previously described (17) using 50 mg protein of each sample or 20 ml of the respective immunoprecipitates for separation by sodium dodecyl sulphate-gel electrophoresis and the antibodies: mouse monoclonal anti-AT3 (1H9, Chemicon), monoclonal mouse anti-beta-actin (AC-15, Sigma), rabbit polyclonal anti-SOD2 (Stressgen, Victoria, Canada), goat polyclonal anti-GST (Amersham Biosciences), polyclonal anti-Afx1X (N-80, Santa Cruz Biotechnology) and mouse anti-HA.11 (Covance). Densitometric quantification was performed using Image J or Quantity One Software (BioRad) and normalization to the corresponding beta-actin levels.
Reporter assays
For reporter assays, 1 × 10 5 HeLa cells/well were seeded on 24-well plates. Cells were transfected the next day with 150 ng of each of the indicated luciferase reporter and expression constructs with Lipofectamine 2000 (Invitrogen) according to the instructions of the manufacturer. The reporter constructs always were cotransfected with 5 ng of the coreporter Renilla luciferase (pRL-CMV, Promega) and the total amount of transfected DNA was kept equal by adding pCMV-b-galactosidase expression plasmid (Clontech). After 24 h, luciferase activities were measured by the dual-luciferase reporter assay system (Promega) according to the instructions of the manufacturer and by a microplate luminometer (Berthold, Bad Wildbad, Germany). Data were normalized for activity of Renilla luciferase to account for transfection efficiency. Expression of ATXN3 and HA-FOXO4 was controlled using 30 ml of the reporter lysates for western blot analysis with 1H9 and HA antibodies.
Immunohistochemical and -fluorescence staining
For immunohistochemical staining, sections of formalin-fixed pons sections from control and SCA3 patients were processed using rabbit polyclonal anti-SOD2 (Stressgen) (1:50) antibody
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and goat anti-rabbit IgG alkaline phosphatase conjugate (Jackson ImmunoResearch, WestGrove, PA, USA) as previously described (10) . Coimmunofluorescence staining was performed as described previously (9,10) with the abovementioned human pons sections by using the anti-ATXN3 (1H9, Chemicon) antibody (1:500) together with anti-Afx1X (Santa Cruz) (1:100) antibody, followed by Texas Red goat anti-mouse and fluorescein goat anti-rabbit antibodies (Jackson ImmunoResearch). Samples were analysed by fluorescence microscopy (Axiovert200, Zeiss).
RNA isolation, cDNA synthesis and RT-qPCR
Total RNA was prepared using RNeasy Plus Mini Kit and QIAshredder columns (Qiagen) according to the instructions of the manufacturer. Synthesis of cDNA was performed in a two-step reverse transcription PCR with M-MLV-Reverse Transcriptase, RNase H Minus, Point Mutant (Promega) and an oligo d(T) primer according to the manufacturer's protocol. RT-qPCR was carried out in a 12 ml reaction mixture containing 6.25 ml SYBR Green (JumpStart Taq ReadyMix, Sigma), 0.375 ml forward and reverse primers (10 pmol/ml; hSOD2-For: TCAGCGGTAGCACCAGCACT and hSOD2-Rev: ATCTGCCGCTTGATGTGAGG), 2.0 ml cDNA and 3.0 ml nuclease-free H 2 O on 7500 Real-Time PCR System (Applied Biosystems). For each transcript, reactions were carried out in triplicate. After pre-incubation for 2 min at 948C, 40 PCR cycles were performed (20 s at 948C followed by 30 s at 658C and 40 s at 728C). The SYBR Green fluorescence signal was measured in each cycle. Relative quantification (△△Ct) was used to calculate gene expression levels in human pons tissue and LC lines by comparison of control and SCA3 patients. The reference gene beta-actin was used for normalization.
Chromatin immunoprecipitation (ChIP) assays
Chromatin immunoprecipitation (ChIP) assays were performed using the SimpleChIP Chromatin IP Kit (New England Biolabs). In brief, 8 × 10 7 LCs of two Ctrl-and two SCA3-LC lines were treated with H 2 O 2 or left untreated as indicated and fixed by adding formaldehyde [1% (v/v) final concentration] for 10 min and cross-linked adducts were further processed according to the instructions of the manufacturer. For ChIP, antibodies were used against ATXN3 (1H9, Chemicon), FOXO4 (#9472, Cell Signaling), Histone H3 (#4620, Cell Signaling) and a control IgG antibody (Santa Cruz). Protein-bound, immunoprecipitated DNA was reverse cross-linked and purified by using DNA purification mini-columns. PCR analyses were performed on chromatin DNA purified from each of the ChIP reactions using specific primers (ChIP-SOD2-For: GTCCCAGCCT GAATTTCC and ChIP-SOD2-Rev: CTAGGCTTCCGGTAAGTG) for the amplification of the human SOD2 gene promoter region between 21398 and 21243. The amount of immunoprecipitated chromatin DNA was normalized to the amount of input chromatin DNA determined by densitometric quantification of the generated PCR products. LCs were seeded on 10 cm and 6-well plates, respectively, and treated the next day with the indicated concentration of H 2 O 2 for the indicated periods of time. For the measurement of intracellular ROS, 2.5 × 10 5 LCs were incubated with the fluorescent dye 2 ′ ,7 ′ -dihydrodichloro-fluorescein (H 2 DCF) (100 mM) for 1 h at 378C and then washed twice in phosphatebuffered saline. Fluorescence was measured on a fluorescence plate reader (Spectramax, Molecular Devices) in triplicates at 485 nm excitation and 530 nm emission wavelengths. ROS values were normalized to cell viability determined by Alamar Blue (1:10) (Biosource) for 1 h at 378C. Fluorescence was measured at 544 nm excitation and 590 nm emission wavelengths. To assess the numbers of living LCs after treatment with H 2 O 2 , 1 × 10 5 cells were seeded in 6-well plates and incubated for the indicated time. Then, cells were pelleted and stained with 0.2% trypan blue for 10 min; live (unstained) and dead (trypan blue positive) cells were counted in a haemocytometer chamber.
Lentiviral knockdown
× 10
5 LCs were seeded in six wells and infected with lentiviruses containing ATXN3-specific shRNA (7) (LVshATXN3) under the control of the U6 promoter in 800 ml/well and collected after 3 days. All viruses were produced as described previously (50) . The titre of the viral preparations was each determined by measuring the activity of viral reverse transcriptase using a colorimetric RT-ELISA (Roche Diagnostics, Indianapolis, IN, USA) and ranged from 2 to 10 × 10 8 viral particles/well. As negative control scrambled shRNA was used (51) . Complementary oligonucleotides of the above shRNAs were annealed and cloned into the SalI and XbaI sites of the pTZU6 + 1 vector. The inserts were released with PstI and StyI and subcloned with the U6 promoter into the XbaI und PstI sites of an HIVderived, self-inactivating lentivector of the third generation (lentiviral vector hplm).
Screening of peptide arrays
FOXO4-interacting ATXN3 peptides were identified using an array containing 116 overlapping peptides as previously described (52) . Each synthetic peptide spotted onto the cellulose membrane is composed of 15 amino acid residues which overlapped in sequence with the next peptide by 12 residues. Washing, blocking and incubation of the membrane with purified recombinant His-FOXO4 (0.1 mM) were performed as previously described (52) . Positive spots were detected by enhanced chemiluminescence using a rabbit anti-His antibody and secondary peroxidase-conjugated anti-rabbit antibody.
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Statistical analyses
Statistical significance was tested using the unpaired Student's t-test.
